STAT3 expression correlates with prognosis of thymic epithelial tumors

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Li, Chao ^a,b   Wang, Zhou ^a,c   Liu, Yan ^b   Wang, Peng ^b   Zhang, Runqi ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b TAIAN CENTRAL HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Prognosis; STAT3 protein; Thymic epithelial tumors

Indexed keywords

STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PROGNOSIS; THYMOMA; NEOPLASMS, GLANDULAR AND EPITHELIAL; THYMUS NEOPLASMS;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROGNOSIS; STAT3 TRANSCRIPTION FACTOR; THYMUS NEOPLASMS;

EID: 84876081954     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-92     Document Type: Article

References (19)

1. Ströbel P, Marx A, Zettl A, Müller-Hermelink HK. Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 2005, 35:805-811. 10.1007/s00595-005-3047-y, 16175459.
2. Pellegrini S, Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 1997, 248:615-633. 10.1111/j.1432-1033.1997.00615.x, 9342212.
3. Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005, 128:140-144. 10.1378/chest.128.1.140, 16002927.
4. Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J. Stat3 activation in human endometrial and cervical cancers. Br J Cancer 2007, 96:591-599. 10.1038/sj.bjc.6603597, 2360038, 17311011.
5. Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 2007, 117:3846-3856. 10.1172/JCI31871, 2096430, 18060032.
6. Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K, Hamilton SR, Amin HM. Constitutive Activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol 2005, 167(4):969-980. 10.1016/S0002-9440(10)61187-X, 1603671, 16192633.
7. Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Nevalainen MT. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol 2008, 172:1717-1728. 10.2353/ajpath.2008.071054, 2408430, 18483213.
8. Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, Friedrich K. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 2007, 9:279-291. 10.1593/neo.06820, 1854849, 17460772.
9. Florian MC, Carina O, Richard M. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005, 7(6):545-555. 10.1593/neo.04571, 1501283, 16036105.
10. Janeen A, Kenneth L, Hikmat AA. Constitutively activated STAT3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin β6. Mol Cell Biol 2007, 27(12):4444-4453. 10.1128/MCB.02404-06, 1900039, 17438134.
11. Cecilia P, Mariana S, Cinthia R. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 2005, 25(12):4826-4840. 10.1128/MCB.25.12.4826-4840.2005, 1140598, 15923602.
12. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002, 26(12):1605-1611. 10.1097/00000478-200212000-00008, 12459627.
13. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002, 94(3):624-632. 10.1002/cncr.10226, 11857293.
14. Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL. Thymoma: Histologic subclassification is an independent prognostic factor. Cancer 1994, 74(2):606-617. 10.1002/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T, 8033040.
15. Kuo TT, Chan JK. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol 1998, 22(12):1474-1481. 10.1097/00000478-199812000-00004, 9850173.
16. Marchevsky AM, Gupta R, Casadio C, Hiroshima K, Jambhekar NA, Kim DJ, Nakatani Y, Okumura M, Rena O, Yoshida S. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol 2010, 41(10):1413-1421. 10.1016/j.humpath.2010.02.012, 20573368.
17. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma. A clinicopathologic review. Cancer 1987, 60(11):2727-2743. 10.1002/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D, 3677008.
18. Marx A, Müller-Hermelink HK. Thymoma and thymic carcinoma. Am J Surg Pathol 1999, 23(6):739-742. 10.1097/00000478-199906000-00017, 10366159.
19. Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002, 95(2):420-429. 10.1002/cncr.10665, 12124843.